to Content

Assoc. Prof. Dr., MBA, cPM Ruth LADENSTEIN Präsidentin, Europäische Gesellschaft für Pädiatrische Onkologie; Leiterin, Koordinierungszentrum für Klinische Studien und Statistik, St. Anna Kinderkrebsforschung, Wien

CV

1982 Doctor of Medicine Degree
1996 Head of the Clinical Trials Unit Studies & Statistics on Integrated Research and Projects, S²IRP of the CCRI - Children s Cancer Research Institute (St. Anna Kinderkrebsforschung e.V.)
1998 Head of the Solid Tumor Oncology Department and Autologous Bone Marrow Transplant Unit (St. Anna Children s Hospital)
1997 Oberarzt (Senior degree-consultant)
1998 University Degree: Assoc. Professor of Paediatrics, University of Vienna
2006 University of Economics - Course International Project Management
2007 Project Management Austria - Certification IPMA-Level B®: Senior Project Manager (cPM)
2007-2009 University of Salzburg - "International Health Care Management" (MBA)

Memberships

Since 2009 President of SIOP EUROPE - SIOP E (board member since 2006)
2007-2011 Advisory Board member of the European SIOP Neuroblastoma Group - SIOPEN president (board member since 1996)
Chair of the Austrian Group for Paediatric Haematology-Oncology (AGPHO member - Arbeitsgruppe für Pädiatrische Haematology-Onkologie)
International Society of Paediatric Oncology (SIOP member)

Publications

Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A and Jürgens H. Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial. J Clin Oncol 2010 Jul 201:28(21):3284-91.
Ladenstein R, Valteau-Couanet D, Brock P, Yaniv I, Castel V, Laureys G, Malis J, Papadakis V, Lacerda A, Ruud E, Kogner P, Garami M, Balwierz W, Schroeder H, Beck-Popovic M, Schreier G, Machin D, Pötschger U, Pearson A. Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study. J Clin Oncol 2010 Jul 20:28(21):3516-24
Ladenstein R, Pötschger U, Siabalis D, Garaventa A, Bergeron C, Lewis IJ, Stein J, Kohler J, Shaw PJ, Holter W, Pistoia V, Michon J. A dose finding study for the effective use of subcutaneous rIL-2 in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem cell reinfusion J Clin Oncol. 2011 Feb 1;29(4):441-8
Gaze MN, Boterberg T, Dieckmann K, Habrand JL, Helfré S, Peylan-Ramu N, Chrzanowska EK, Schreier G, Ladenstein R. Development of an electronic database for quality assurance of radiotherapy in the International Society of Paediatric Oncology (Europe) high risk neuroblastoma study. Radiother Oncol. 2010 Dec;97(3):593-5.

Awards

1998 Dachverband der Österreichischen Kinder-Krebs-Hilfe-Organisation, Scientific Award for Paediatric Haemato-Oncology: Ladenstein R, Pearce R, Hartmann O, Patte C, Goldstone T, Philip T: High-Dose Chemotherapy with Autologous Bone Marrow Rescue in Children With Poor-Risk Burkitt's Lymphoma: A Report From the European Lymphoma Bone Marrow Transplantation Registry Blood. 1997 Oct. 15;90(8):2921-30
2010 Austrian Champions in European Research Award 7th Framework Programme of the EU: Health.2010.2.2.1-3
2010 47th Annual Meeting of the American Society of Clinical Oncology, June 2011, Chicago, USA: oral presentation (plenary session) Ladenstein R., Pötschger U., Luksch R., Brock P., Castel V., Yaniv I., Papadakis V., Laureys G., Malis J., Balwierz W., Ruud E., Kogner P., Schroeder H., Forjaz De Lacerda A., Beck-Popovic M., Bician P., Garami M., Trahair T., Pearson ADJ., Valteau-Couanet D.: Busulphan-Melphalan is the Superior Myeloablative Therapy (MAT) for High Risk Neuroblastoma: Results from the HR-NBL1/SIOPEN Trial.
2011 Wissenschaftspreis der AG Wissenschaft und Forschung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde ÖGK im Bereich der hämato-onkologischen Forschung
R. Ladenstein et al, Journal of Clinical Oncology 2010: (Volume: 28, Issue: 20, Pages: 3284-3291; Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
R. Ladenstein et al, Journal of Clinical Oncology 2010: Volume: 28, Issue: 21, Pages: 3516-3524- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study